Scientists test drug to boost Radiation's power against sarcoma
NCT ID NCT05938374
Summary
This study tested whether adding a drug called Fluzoparib to a specific type of radiation treatment before surgery could help people with soft tissue sarcoma in their arms, legs, or torso. The goal was to see if this combination was safe, effective at controlling the cancer, and led to fewer complications and better quality of life after treatment. Researchers enrolled 52 patients to compare the outcomes of radiation alone versus radiation plus the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Jishuitan Hospital
Beijing, Beijing Municipality, China
-
Cancer Hospital and Institute, National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical Center
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.